Hermine O

References (2)

Title : Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial - Dubois_2023_Alzheimers.Res.Ther_15_39
Author(s) : Dubois B , Lopez-Arrieta J , Lipschitz S , Triantafyllos D , Spiru L , Moroz S , Venger O , Vermersch P , Moussy A , Mansfield CD , Hermine O , Tsolaki M
Ref : Alzheimers Res Ther , 15 :39 , 2023
Abstract : Dubois_2023_Alzheimers.Res.Ther_15_39
ESTHER : Dubois_2023_Alzheimers.Res.Ther_15_39
PubMedSearch : Dubois_2023_Alzheimers.Res.Ther_15_39
PubMedID: 36849969

Title : Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial - Piette_2011_Alzheimers.Res.Ther_3_16
Author(s) : Piette F , Belmin J , Vincent H , Schmidt N , Pariel S , Verny M , Marquis C , Mely J , Hugonot-Diener L , Kinet JP , Dubreuil P , Moussy A , Hermine O
Ref : Alzheimers Res Ther , 3 :16 , 2011
Abstract : Piette_2011_Alzheimers.Res.Ther_3_16
ESTHER : Piette_2011_Alzheimers.Res.Ther_3_16
PubMedSearch : Piette_2011_Alzheimers.Res.Ther_3_16
PubMedID: 21504563